SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-006491
Filing Date
2019-02-12
Accepted
2019-02-12 11:36:23
Documents
1
Group Members
NQ HCIF GENERAL PARTNER, L.P.NQ HCIF GP, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv512880_sc13ga.htm SC 13G/A 76338
  Complete submission text file 0001144204-19-006491.txt   78148
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88023 | Film No.: 19589008
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609 919-459-8620
NovaQuest Pharma Opportunities Fund III, L.P. (Filed by) CIK: 0001506260 (see all company filings)

IRS No.: 800647974 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A